March 22, 2023 12:09 AM
Latest:
  • Twitter’s Role In The Silicon Valley Bank Collapse
  • Did Coca-Cola Ever Really Leave Russia?
  • Trudeau Chief Of Staff Katie Telford Testifying On Chinese Interference? Liberals Want An Election Instead
  • Unlike Its Pornstars, Pornhub’s New Owner Won’t Reveal Executives’ Identity Because Of “Stigma”
  • Peter Grandich: People Are More Concerned About Running Out of Money than Passing Away
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

Thank you!

You have successfully joined our subscriber list.

.

  • Home
  • Latest
    • Automotive
    • Briefing
    • Cannabis
    • Commentary
    • Education
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Psychedelics
    • Resources
    • Technology
  • Cannabis
  • Technology
  • Company Profiles
    • Hemlo Explorers
    • HydroGraph Clean Power
    • Power Nickel
    • Prime Meridian Resources
    • Riverside Resources
    • RooGold Inc
    • Slave Lake Zinc
    • Spey Resources
    • Trillion Energy
    • Vortex Metals
  • Resources
  • About
  • Contact Us
  • Advertise With Us

Psychedelics

Briefing Psychedelics 

Field Trip Health To Divide Into Two Separate Firms

April 29, 2022 8:01 AMApril 29, 2022 8:01 AM Jay Lutz 0 Comments Field Trip Health, Reunion Neuroscience

Field Trip Health (TSX: FTRP) is set to be split into two separate firms. The company last night indicated that

Share
Tweet
Share
Read more
Briefing Psychedelics 

Mydecine Announces 50 To 1 Share Consolidation

April 14, 2022 8:14 AMApril 14, 2022 8:14 AM Jay Lutz 0 Comments Mydecine Innovations

Mydecine Innovations (NEO: MYCO) is the latest firm to announce a reverse stock split amid a recent trend amongst small

Share
Tweet
Share
Read more
Briefing Psychedelics 

Numinus Wellness To Acquire Novamind In All Stock Transaction At $0.44 Per Share

April 12, 2022 7:56 AMApril 12, 2022 7:56 AM Jay Lutz 0 Comments Novamind, Numinus Wellness Inc

Consolidation within the psychedelics space is getting underway, with the announcement this morning that Numinus Wellness (TSX: NUMI) will be

Share
Tweet
Share
Read more
Briefing Psychedelics 

Red Light Holland Acquires 100 Acres Of Land To Grow Mushrooms

April 11, 2022 9:09 AMApril 11, 2022 9:10 AM Jay Lutz 0 Comments Red Light Holland

Evidently there is big money within the mushroom market. Red Light Holland (CSE: TRIP) this morning indicated it is dropping

Share
Tweet
Share
Read more
Briefing Psychedelics 

Mind Medicine CFO Quits Ahead Of Release Of 2021 Financial Results

March 28, 2022 6:45 AMMarch 27, 2022 11:20 PM Jay Lutz 0 Comments Mind Medicine, MindMed

It’s always a positive sign when a chief financial officer resigns the last business day before annual filings are to

Share
Tweet
Share
Read more
Briefing Psychedelics 

Core One Labs Looks To Sell Out To Big Pharma As Capital Dries Up In Psychedelics Space

March 20, 2022 9:00 AMMarch 20, 2022 12:15 AM Jay Lutz 0 Comments Core One Labs Inc

Evidently there has been a shift of strategy behind the scenes at Core One Labs (CSE: COOL). The company late

Share
Tweet
Share
Read more
Briefing Psychedelics 

Mind Cure Gives Up On Psychedelics, Fires C-Suite, And Reverts To Shell After Strategic Review

March 16, 2022 11:58 AMMarch 16, 2022 10:51 AM Jay Lutz 0 Comments Mind Cure Health

In a sign of what’s to come for most psychedelic-related names, Mind Cure Health (CSE: MCUR) this morning effectively announced

Share
Tweet
Share
Read more
Briefing News Psychedelics 

Bright Minds Moves Into Clinical Development Stage Following Positive Toxicity Results

March 14, 2022 7:54 AMMarch 14, 2022 7:54 AM Jay Lutz 0 Comments Bright Minds Biosciences

Drug development continues for the Bright Minds Biosciences (CSE: DRUG) lead product. The firm this morning published positive results from

Share
Tweet
Share
Read more
Briefing Healthcare Psychedelics 

Mind Medicine Sees Final Co-Founder Leave The Company

January 9, 2022 3:07 PMJanuary 9, 2022 10:08 AM Jay Lutz 0 Comments Mind Medicine, MindMed

Mind Medicine (NEO: MMED) appears to now be fully under new management. On Friday evening, after the close of markets,

Share
Tweet
Share
Read more
Biotech Briefing Psychedelics 

MindMed Concludes Phase 1 Clinical Trial Of Psychedelic Derivative Drug For Opioid Use Disorder

January 4, 2022 10:29 AMJanuary 4, 2022 9:45 AM ER Velasco 0 Comments Mind Medicine, MindMed

Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, has recently concluded the phase 1 clinical trial for its

Share
Tweet
Share
Read more
  • ← Previous
  • Next →

Briefings

Twitter’s Role In The Silicon Valley Bank Collapse
Briefing Macro 

Twitter’s Role In The Silicon Valley Bank Collapse

March 21, 2023 4:42 PM JP Alegre 0

The historic $42 billion bank run on Silicon Valley Bank was driven by a tweetstorm from concerned investors expressing fears

Did Coca-Cola Ever Really Leave Russia?
Briefing Food 

Did Coca-Cola Ever Really Leave Russia?

March 21, 2023 3:47 PM JP Alegre 0
Trudeau Chief Of Staff Katie Telford Testifying On Chinese Interference? Liberals Want An Election Instead
Briefing Macro 

Trudeau Chief Of Staff Katie Telford Testifying On Chinese Interference? Liberals Want An Election Instead

March 21, 2023 3:04 PM ER Velasco 0
Unlike Its Pornstars, Pornhub’s New Owner Won’t Reveal Executives’ Identity Because Of “Stigma”
Briefing Entertainment 

Unlike Its Pornstars, Pornhub’s New Owner Won’t Reveal Executives’ Identity Because Of “Stigma”

March 21, 2023 2:18 PM ER Velasco 0
Peter Grandich: People Are More Concerned About Running Out of Money than Passing Away
Briefing Macro Video Series 

Peter Grandich: People Are More Concerned About Running Out of Money than Passing Away

March 21, 2023 1:30 PM Jay Lutz 0
Woke Vs. Wall Street: Biden’s First Veto Lands On ESG Investments Of Retirement Plans
Briefing Macro 

Woke Vs. Wall Street: Biden’s First Veto Lands On ESG Investments Of Retirement Plans

March 21, 2023 12:18 PM ER Velasco 0
Bill Ackman, Who Pushed For “Aggressive” Interest Rate Hikes, Now Wants The Fed To Pause
Briefing 

Bill Ackman, Who Pushed For “Aggressive” Interest Rate Hikes, Now Wants The Fed To Pause

March 21, 2023 11:27 AM ER Velasco 0

Spotlight Series

Peter Grandich: People Are More Concerned About Running Out of Money than Passing Away
Briefing Macro Video Series 

Peter Grandich: People Are More Concerned About Running Out of Money than Passing Away

March 21, 2023 1:30 PM Jay Lutz 0

Returning today on the Daily Dive is Peter Grandich, CEO of Peter Grandich & Company. Peters sits with us today

News

First Phosphate Recovers 91.4% Of Apatite In Metallurgy Tests, Produces 40.2% P2O5 Concentrate
Briefing News Resources 

First Phosphate Recovers 91.4% Of Apatite In Metallurgy Tests, Produces 40.2% P2O5 Concentrate

March 20, 2023 9:28 AM Jay Lutz 0

Early metallurgy results are in for First Phosphate (CSE: PHOS) in conjunction with an ongoing preliminary economic assessment being conducted

Eguana Sees ITOCHU Increase Stake To 12.95%
Briefing News Technology 

Eguana Sees ITOCHU Increase Stake To 12.95%

March 16, 2023 9:00 AM Jay Lutz 0
Carlyle Commodities Hits 689 Metres Of 0.51 g/t Gold
Briefing News Resources 

Carlyle Commodities Hits 689 Metres Of 0.51 g/t Gold

March 15, 2023 10:06 AM Jay Lutz 0
First Phosphate: New Report Suggests Flagship Property Holds ESG-Compliant Source Of Phosphate For LFP Battery Industry
Briefing News Resources 

First Phosphate: New Report Suggests Flagship Property Holds ESG-Compliant Source Of Phosphate For LFP Battery Industry

March 14, 2023 11:22 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Blockchain
  • Bonds
  • Briefing
  • Cannabis
  • Commentary
  • Education
  • Energy
  • Entertainment
  • Esports
  • ETFs
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Lithium
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Politics
  • Psychedelics
  • Real Estate
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2023 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.